Giant Cell Arteritis Clinical Trials in Chicago, Illinois
2 recruitingChicago, Illinois
Showing 1–2 of 2 trials
Recruiting
Phase 2
Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis
Giant Cell Arteritis (GCA)
National Institute of Allergy and Infectious Diseases (NIAID)78 enrolled7 locationsNCT07108387
Recruiting
One-Time DNA Study for Vasculitis
Microscopic PolyangiitisGiant Cell ArteritisTakayasu's Arteritis+3 more
University of Pennsylvania1,000 enrolled14 locationsNCT01241305